Angioedema - 90 Studies Found
| Completed |
: A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161 : Hereditary Angioedema : 2014-04-24 : Drug: BCX4161 Each subject will receive Treatments A, B, and C in an open-label, randomized sequence wit |
| Completed |
: First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers : Hereditary Angioedema : 2015-05-13 :
|
| Completed |
: Study to Determine How BCX4161 is Metabolized and Eliminated by the Body : Hereditary Angioedema : 2014-08-14 : Drug: BCX4161 |
| Completed |
: Patient Registry Study of Berinert® in Normal Clinical Practice : Includes: Hereditary Angioedema : 2010-04-12 : Biological: Berinert® (C1 Esterase Inhibitor) Berinert® is marketed as a lyophilized concentra |
| Active, not recruiting |
: A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions : Hereditary Angioedema : 2017-04-24 :
|
| Completed |
: An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates : Hereditary Angioedema : 2016-06-28 : Drug: BCX7353 and probes |
| Completed |
: Hereditary AngioEdema, Neurobiology and Psychopathology :
: Other: Clinical and psychopathological assessment of HAE patients |
| Completed |
: Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult Subjects : Hereditary Angioedema (HAE) : 2015-12-21 :
|
| Completed |
: A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects : Hereditary Angioedema (HAE) : 2013-08-08 :
|
| Completed |
: A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration :
: 2009-02-25 : Drug: Recombinant Human C1 Inhibitor 50 IU/kg "rhC1INH", "IV" injection over 4 to 5 |